Domov › Alzheimerova choroba › Georgia
Klinické štúdie Alzheimerova choroba v štáte Georgia
24 štúdií pre Alzheimerova choroba hľadá účastníkov v zariadeniach v štáte Georgia.
Mestá v štáte Georgia
Oficiálny text štúdie (anglicky)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Augusta
- Clinical Site, Snellville
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- CenExeli Research LLC, Savannah
Prebieha náborFáza 2
Vek 55 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2611, Atlanta
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Accel Research - NeuroStudies, Decatur
Prebieha náborFáza 4
Vek 50 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07633470A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0004, Decatur
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 18 až 80 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07780383A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Agile Clinical Research Trials, LLC, Atlanta
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Columbus Memory Center, Columbus
- Center for Advanced Research & Education Flourish-Gainesville, Gainsville
Prebieha náborFáza 2
Vek 55 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Grady Memorial Hospital, Atlanta
- Alzheimer's Research and Treatment Center - Columbus, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- a 2 ďalších
Prebieha náborFáza 3
Vek 50 až 90 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Agile Clinical Research Trials, LLC, Atlanta
Prebieha náborFáza 3
Vek 55 až 90 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- CenExel iResearch, LLC, Decatur
- CenExel iResearch, LLC, Savannah
Prebieha náborFáza 2
Vek 55 až 90 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel iResearch, LLC ( Site 1015), Decatur
Prebieha náborFáza 2
Vek 50 až 85 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel iResearch, LLC (CenExel iRA), Decatur
Prebieha náborFáza 1
Vek 50 až 85 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT06297590AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Alzheimer's Research and Treatment Center (Columbus), Columbus
Prebieha náborFáza 1
Vek 65 až 80 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT07158905A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Center for Advanced Research & Education, Gainesville
Prebieha náborFáza 3
Vek 60 až 85 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Emory University School of Medicine, Atlanta
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06563895A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Prebieha náborFáza 2/3Vítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Prebieha náborFáza 2/3Vítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT06647498Moving Yourself in Space and Time: MYSTIC
- Emory University, Executive Park, Wesley Woods, Atlanta
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 až 79 · Všetky pohlavia · Aktualizované 13. 7. 2026 · NCT07697664A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Center for Advanced Research & Education, Gainesville
- North Georgia Clinical Research, Woodstock
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 45 až 85 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT06657768Inspiring Seniors Towards Exercise Promotion to Protect Cognition
- Emory University, Atlanta
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 65 a viac · Všetky pohlavia · Aktualizované 30. 4. 2026 · NCT06496425Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Emory Rehabilitation Hospital, Atlanta
Prebieha nábor
Vek 50 až 90 · Všetky pohlavia · Aktualizované 2. 3. 2026 · NCT06484244Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Reminiscent, Valdosta
Prebieha nábor
Vek 65 až 90 · Všetky pohlavia · Aktualizované 4. 2. 2026 · NCT05205980A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
Prebieha náborFáza 1
Vek 65 až 85 · Všetky pohlavia · Aktualizované 7. 1. 2026 · NCT07218081Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.